Estrogen Replacement Therapy Market Size & Share, by Route of Administration (Oral, Topical, Transdermal, Vaginal and Parenteral) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 2374
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Estrogen Replacement Therapy Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2025-2037.

As per the National Health Service in UK, the menopause usually occurs between the age of 45 and 55 years. The average age for a woman to reach menopause in the United Kingdom is 51 after which the estrogen levels begin to decrease in the body. However, it was reported that about 1 in every 100 women experience menopause before the age of 40 years, which is known as premature menopause or premature ovarian insufficiency. As a result of this, the number of women going through the menopause is predicted to increase at a high rate, thereby raising the demand for estrogen replacement therapy.


Get more information on this report: Request Free Sample PDF

Estrogen Replacement Therapy Sector: Growth Drivers and Challenges

Growth Drivers

Relief from Menopausal Symptoms to Raise the Demand for Estrogen Therapy

According to a report published by the Centers for Disease Control and Prevention in 2017, around 27.1% of postmenopausal women between the ages 40 and 59 were highly likely to have trouble falling asleep as compared with premenopausal women. Moreover, about 55.1% of postmenopausal women aged between 40 and 59 were more likely than premenopausal women to wake up not feeling well rested for at least 4 days per week. Growing awareness among women about the serious implications of menopause which can lead to disorders and discomfort and affect their daily lives has resulted in the increasing adoption of hormone therapies such as estrogen replacement therapy by women. This is anticipated to lead to substantial market growth during the forecast period. 

Availability of Various Types of Therapies to Drive the Market Growth

The rising population of post-menopausal women is attributed to the growing demand for improved estrogen replacement therapies with better efficacy and lesser side-effects. Further, the benefits of estrogen therapy in improving health conditions such as osteoporosis are estimated to increase the demand in near future. On account of these factors, the market growth is anticipated to witness a notable hike over the forecast period.

Challenges

Side-Effects Linked with the Use of Estrogen Therapy to Restrict the Market Growth

Medications containing hormones show certain side-effects which might be either mild or serious. Moreover, estrogen replacement therapy cannot be used in case women have the conditions such as liver problems, bleeding disorder, pregnancy, severe reactions to estrogen medicines among other health conditions. This is estimated to hamper the market growth in the next few years.

Estrogen Replacement Therapy Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Estrogen Replacement Therapy Segmentation

The market is segmented by route of administration and by region. On the basis of route of administration, the market is segmented into oral, topical, transdermal, vaginal and parenteral, out of which, the oral segment is anticipated to hold the largest share in the estrogen replacement therapy market on account of ease of administration of estrogen in the oral forms such as tablets and capsules.  Bijuva, an estrogen and progesterone therapy manufactured by TherapeuticsMD, Inc., received FDA approval in 2018.The therapy is for oral use in the form of capsules and is recommended to be taken one daily.

Our in-depth analysis of the global market includes the following segments

By Route of Administration

  • Oral
  • Topical
  • Transdermal
  • Vaginal
  • Parenteral

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Estrogen Replacement Therapy Industry - Regional Synopsis

North America industry is poised to dominate majority revenue share by 2037, driven by rising number of older women undergoing the menopause, which is increasing the demand for estrogen therapy in order to provide comfort and make daily life easier. The market in Europe is projected to hold a significant share in the market as well owing to advancements in technology in the healthcare industry which is resulting in development of new and improved estrogen replacement therapies with lesser side effects.

Get more information on this report: Request Free Sample PDF

Companies Dominating the Estrogen Replacement Therapy Landscape

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Novartis
    • Bayer Healthcare
    • Eli Lilly
    • Novo Nordisk
    • Merck
    • Allergan
    • Orion Pharma
    • TherapeuticsMD, Inc.

Author Credits:  Radhika Pawar


  • Report ID: 2374
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Estrogen Replacement Therapy Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2025-2037.

Estrogen Replacement Therapy Market size is projected to witness lucrative growth rate during the forecast period i.e., between 2025-2037.

North America industry is poised to dominate majority revenue share by 2037, driven by rising number of older women undergoing the menopause, which is increasing the demand for estrogen therapy in order to provide comfort and make daily life easier.

The major players in the market are Abbott Laboratories, Pfizer Inc., Novartis, Bayer Healthcare, Eli Lilly, Novo Nordisk, Merck, Allergan, Orion Pharma and TherapeuticsMD, Inc.
Estrogen Replacement Therapy Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample